Showing results (41-50 of 526) with videos related to
Sort By:
Pageof 53
Clinical Pharmacology and Therapeutics|November 1, 1984
Mephenytoin and sparteine pharmacogenetics in Canadian CaucasiansT Inaba, M Jurima, M Nakano, et al.Pharmacogenetics|February 1, 1992
Variability of acetaminophen metabolism in Caucasians and OrientalsM Patel, B K Tang, W KalowPharmacogenetics|February 1, 1995
(S)oxazepam glucuronidation is inhibited by ketoprofen and other substrates of UGT2B7M Patel, B K Tang, W KalowPharmacogenetics|September 10, 1998
Hypothesis: comparisons of inter- and intra-individual variations can substitute for twin studies in drug researchW Kalow, B K Tang, L EndrenyiBiomedical Mass Spectrometry|September 1, 1984
Determination of phenobarbital, p-hydroxyphenobarbital and phenobarbital-N-glucoside in urine by gas chromatography chemical ionization mass spectrometryB K Tang, B Yilmaz, W KalowDrug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenaseT Inaba, M Jurima, W A Mahon, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1979
Metabolic fate of phenobarbital in man. N-Glucoside formationB K Tang, W Kalow, A A GreyClinical Pharmacology and Therapeutics|March 1, 1983
Comparative pharmacogenetics of sparteine and debrisoquineT Inaba, A Vinks, S V Otton, et al.Clinical Pharmacology and Therapeutics|April 1, 1979
Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterasesD J Stewart, T Inaba, M Lucassen, et al.Research Communications in Chemical Pathology and Pharmacology|July 1, 1978
Amobarbital metabolism in man: N-glucoside formationB K Tang, W Kalow, A A GreyPageof 53